Showing results (291-300 of 373) with videos related to

Sort By:
Pageof 38
Nephron|January 1, 1990
Anionic versus cationic immunoglobulin clearance in normal subjects: a novel approach to the evaluation of charge permselectivityU Di Mario, A Cancelli, P Pietravalle, et al.
Diabetes|July 26, 2000
The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expressionG Pugliese, F Pricci, G Leto, et al.
Diabetes|August 1, 1991
Abnormalities of cognitive functions in IDDM revealed by P300 event-related potential analysis. Comparison with short-latency evoked potentials and psychometric testsG Pozzessere, E Valle, S de Crignis, et al.
The Journal of Endocrinology|November 3, 2001
IGFBPs modulate IGF-I- and high glucose-controlled growth of human retinal endothelial cellsS Giannini, B Cresci, L Pala, et al.
Acta Diabetologica|July 9, 2020
Low-carbohydrate diets and type 2 diabetes treatment: a meta-analysis of randomized controlled trialsG A Silverii, L Botarelli, I Dicembrini, et al.
Diabetes, Obesity & Metabolism|April 8, 2015
Treatment escalation options for patients with type 2 diabetes after failure of exenatide twice daily or glimepiride added to metformin: results from the prospective European Exenatide (EUREXA) studyG Schernthaner, J Rosas-Guzmán, F Dotta, et al.
Journal of Autoimmunity|February 1, 1996
Antineutrophil cytoplasmic antibodies are present in long standing type 1 diabetics but do not correlate with selective proteinuriaP Pietravalle, G Monteleone, S Morano, et al.
The European Journal of Neuroscience|June 1, 1996
Peripheral, but not central, nervous system abnormalities are reversed by pancreatic islet transplantation in diabetic Lewis ratsS Morano, M Sensi, S Di Gregorio, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 2, 2001
Accelerated diabetic glomerulopathy in galectin-3/AGE receptor 3 knockout miceG Pugliese, F Pricci, C Iacobini, et al.
European Journal of Clinical Investigation|August 13, 2004
GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patientsG Schernthaner, A Grimaldi, U Di Mario, et al.
Pageof 38